„Today, we are thrilled to announce the signing of the lease contract for our new offices in Bonn, Germany. The construction of the office and lab spaces will begin soon and we look forward to moving into this space, which will become our primary base of operations. The new office site allows NEUWAY to continue to grow steadily and drive the pre-clinical development of our innovative drug delivery technology EnPC® transporting CNS-related therapeutics across the blood-brain-barrier.
We would like to send a big thank you to Stefan Sauerborn from Wirtschaftsförderung Bonn and Fabian Udelhofen from Udelhofen Immobilien GmbH, Herbert-Worch- Stiftung and NEUWAY’s existing shareholders for their support. NEUWAY is proud to be and to remain a member of the vibrant scientific community in #Bonn.“
Wir wünschen viel Erfolg an diesem hervorragenden Standort